Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Mesenchymal Stem Cells (MSCs): A Novel Therapy for Type 2 Diabetes
Shuang Gao, Yuanyuan Zhang, Kaini Liang, et al.
Stem Cells International (2022) Vol. 2022, pp. 1-17
Open Access | Times Cited: 26

Showing 1-25 of 26 citing articles:

Exosomes derived from mesenchymal stem cells in diabetes and diabetic complications
Yurui Jiao, Kaixuan Chen, Xiang Tang, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 4
Open Access | Times Cited: 19
The issue of heterogeneity of MSC-based advanced therapy medicinal products–a review
Ana Bajc Česnik, Urban Švajger
Frontiers in Cell and Developmental Biology (2024) Vol. 12
Open Access | Times Cited: 19
Safety and Preliminary Efficacy of Mesenchymal Stromal Cell (ORBCEL-M) Therapy in Diabetic Kidney Disease: A Randomized Clinical Trial (NEPHSTROM)
Norberto Perico, Giuseppe Remuzzi, Matthew D. Griffin, et al.
Journal of the American Society of Nephrology (2023) Vol. 34, Iss. 10, pp. 1733-1751
Open Access | Times Cited: 31
A Narrative Review of Diabetic Macroangiopathy: From Molecular Mechanism to Therapeutic Approaches
Jiacheng Yin, Xiaoxu Fu, Yue Luo, et al.
Diabetes Therapy (2024) Vol. 15, Iss. 3, pp. 585-609
Open Access | Times Cited: 9
Meta-analysis shows that mesenchymal stem cell therapy can be a possible treatment for diabetes
Umm E. Habiba, Nasar Khan, David Lawrence Greene, et al.
Frontiers in Endocrinology (2024) Vol. 15
Open Access | Times Cited: 5
Mesenchymal Stromal Cell-Based Products: Challenges and Clinical Therapeutic Options
Débora B. Mello, Fernanda Mesquita, Danúbia Silva dos Santos, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 11, pp. 6063-6063
Open Access | Times Cited: 5
The importance of stem cells in the treatment of type 1 diabetes, type 2 diabetes and diabetes complications
Monika Kamińska, Maria Jasiewicz, Magdalena Miernik-Skrzypczak, et al.
Quality in Sport (2025) Vol. 37, pp. 57420-57420
Open Access
Tissue Engineering and Regenerative Medicine: Perspectives and Challenges
Van T. Hoang, Quyen Thi Nguyen, Trang Thi Kieu Phan, et al.
MedComm (2025) Vol. 6, Iss. 5
Open Access
Enhancing the therapeutic efficacy of mesenchymal stem cell transplantation in diabetes: Amelioration of mitochondrial dysfunction-induced senescence
Hyun Jik Lee, Chang Woo Chae, Ho Jae Han
Biomedicine & Pharmacotherapy (2023) Vol. 168, pp. 115759-115759
Open Access | Times Cited: 9
Revolutionizing type 1 diabetes management: Exploring oral insulin and adjunctive treatments
Mohsen Nabi‐Afjadi, S. Ostadhadi, Mahsa Liaghat, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 176, pp. 116808-116808
Open Access | Times Cited: 3
Exosomes derived from hypoxia-preconditioned mesenchymal stem cells (hypoMSCs-Exo): advantages in disease treatment
Jia Dong, Bin Wu, Weidong Tian
Cell and Tissue Research (2023) Vol. 392, Iss. 3, pp. 621-629
Closed Access | Times Cited: 6
Treatment of type 2 diabetes mellitus with stem cells and antidiabetic drugs: a dualistic and future-focused approach
Priyamvada Arte, Kanchanlata Tungare, Mustansir Bhori, et al.
Human Cell (2023) Vol. 37, Iss. 1, pp. 54-84
Closed Access | Times Cited: 6
Reversing Uteropathies Including Cancer-Like Changes in Mice by Transplanting Mesenchymal Stromal Cells or XAR Treatment
Pushpa Singh, Siddhanath Metkari, Anish Tripathi, et al.
Stem Cell Reviews and Reports (2023) Vol. 20, Iss. 1, pp. 258-282
Closed Access | Times Cited: 4
The effect of diabetes mellitus on differentiation of mesenchymal stem cells into insulin-producing cells
Omar I. Badr, Mohamed M. Kamal, Shohda A. El‐Maraghy, et al.
Biological Research (2024) Vol. 57, Iss. 1
Open Access | Times Cited: 1
Successful lifestyle modifications may underlie umbilical cord-mesenchymal stromal cell effects in type 2 diabetes mellitus
Alexandra Papadopoulou, Konstantinos I. Papadopoulos
World Journal of Diabetes (2023) Vol. 14, Iss. 3, pp. 347-351
Open Access | Times Cited: 3
Applicability of Mesenchymal Stem Cell-Derived Exosomes as a Cell-Free miRNA Therapy and Epigenetic Modifiers for Diabetes
Shikha Sharma, Ramesh Bhonde
Epigenomics (2023) Vol. 15, Iss. 24, pp. 1323-1336
Closed Access | Times Cited: 3
The ameliorating effects of mesenchymal stem cells compared to α‐tocopherol on apoptosis and autophagy in streptozotocin‐induced diabetic rats: Implication of PI3K/Akt signaling pathway and entero‐insular axis
Heba A. Mubarak, Manal Mohamed Kamal, Yossra Mahmoud, et al.
Journal of Cellular Biochemistry (2023) Vol. 124, Iss. 11, pp. 1705-1719
Closed Access | Times Cited: 2
Mitochondrial Dynamics and Research Status of Hypoglycemic Drugs and Type 2 Diabetes Mellitus
颖 屈
Journal of Clinical Personalized Medicine (2024) Vol. 03, Iss. 02, pp. 223-228
Open Access
Bone marrow mesenchymal stem cell and mononuclear cell combination therapy in patients with type 2 diabetes mellitus: a randomized controlled study with 8-year follow-up
Zhixian Wu, Shulin Huang, Shasha Li, et al.
Stem Cell Research & Therapy (2024) Vol. 15, Iss. 1
Open Access
Mesenchymal Stem Cells and Their Extracellular Vesicles Are a Promising Alternative to Antibiotics for Treating Sepsis
Yu Jiang, Young Goo Song, Qin Zeng, et al.
Bioengineering (2024) Vol. 11, Iss. 11, pp. 1160-1160
Open Access
Intrapancreatic autologous stem cell therapy for type 1 diabetes – an experimental study
Sagar Jawale
Annals of Medicine and Surgery (2023) Vol. 85, Iss. 9, pp. 4355-4371
Open Access | Times Cited: 1
Adipose Stem Cells for Metabolic Disorders: The Findings and Potential Applications
Huệ Vũ Thị, Tiep Tien Nguyen, Yen-Vy Nguyen Thi, et al.
Elsevier eBooks (2024), pp. 115-122
Closed Access
The role of fetal pancreatic islet cell transplantation in the treatment of type 2 diabetes mellitus
Indira Kaibagarova, С. С. Сапарбаев, Raisa Aringazina, et al.
Journal of Diabetes & Metabolic Disorders (2024) Vol. 23, Iss. 2, pp. 1949-1957
Closed Access
Mesenchymal Stem Cells Suppress Kidney Injury molecule-1 Associated with Inhibition of Renal PKC/ NF-Kβ / STAT3 Fibrotic Signaling Pathway in Rats with Diabetic Nephropathy
Hasnaa Ali Ebrahim, Asmaa Mohammed AlMohanna, Ayed A. Shati, et al.
Archives of Medical Science (2024)
Open Access
Stem Cell- and Stem Cell-Free-Based Therapies: Pros and Cons
Halimeh Mobarak, Reza Rahbarghazi‬, Mahdi Mahdipour
West Kazakhstan Medical Journal (2023)
Open Access
Page 1 - Next Page

Scroll to top